These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 7006881)
1. Successful treatment of an institutional outbreak of shigellosis. Bachrach SJ Clin Pediatr (Phila); 1981 Feb; 20(2):127-31. PubMed ID: 7006881 [TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole therapy for shigellosis. Nelson JD; Kusmiesz H; Jackson LH; Woodman E JAMA; 1976 Mar; 235(12):1239-43. PubMed ID: 765518 [TBL] [Abstract][Full Text] [Related]
3. Comparison of trimethoprim-sulfamethoxazole and ampicillin theraphy for shigellosis in ambulatory. Nelson JD; Kusmiesz H; Jackson LH J Pediatr; 1976 Sep; 89(3):491-3. PubMed ID: 1048183 [TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole compared to ampicillin in the treatment of shigellosis. Chang MJ; Dunkle LM; Van Reken D; Anderson D; Wong ML; Feigin RD Pediatrics; 1977 May; 59(5):726-9. PubMed ID: 323811 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic treatment of acute shigellosis: failure of cefamandole compared with trimethoprim/ sulfamethoxazole and ampicillin. Orenstein WA; Ross L; Overturf GD; Wilkins J; Redfield DR; Underman A Am J Med Sci; 1981; 282(1):27-33. PubMed ID: 7270569 [TBL] [Abstract][Full Text] [Related]
6. An epidemic of shigellosis in a day-care centre in Quebec. Can Med Assoc J; 1985 Feb; 132(4):399-400. PubMed ID: 3882213 [No Abstract] [Full Text] [Related]
7. Transmission risk factors and treatment of pediatric shigellosis during a large daycare center-associated outbreak of multidrug resistant Shigella sonnei: implications for the management of shigellosis outbreaks among children. Arvelo W; Hinkle CJ; Nguyen TA; Weiser T; Steinmuller N; Khan F; Gladbach S; Parsons M; Jennings D; Zhu BP; Mintz E; Bowen A Pediatr Infect Dis J; 2009 Nov; 28(11):976-80. PubMed ID: 19738503 [TBL] [Abstract][Full Text] [Related]
8. Multistate outbreak of Shigella sonnei gastroenteritis--United States. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1987 Jul; 36(27):440-2, 448-9. PubMed ID: 3110572 [No Abstract] [Full Text] [Related]
9. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Gotuzzo E; Oberhelman RA; Maguiña C; Berry SJ; Yi A; Guzman M; Ruiz R; Leon-Barua R; Sack RB Antimicrob Agents Chemother; 1989 Jul; 33(7):1101-4. PubMed ID: 2675757 [TBL] [Abstract][Full Text] [Related]
10. [Shigellosis in children of the IX region of Chile: clinical and epidemiologic aspects and antibiotic sensitivity]. Boehme C; Rodríguez G; Illesca V; Reydet P; Serra J Rev Med Chil; 1992 Nov; 120(11):1261-6. PubMed ID: 1340946 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis. Ashkenazi S; Amir J; Waisman Y; Rachmel A; Garty BZ; Samra Z; Varsano I; Nitzan M J Pediatr; 1993 Nov; 123(5):817-21. PubMed ID: 8229498 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of an intervention program for the control of an outbreak of shigellosis among institutionalized persons. Mahoney FJ; Farley TA; Burbank DF; Leslie NH; McFarland LM J Infect Dis; 1993 Nov; 168(5):1177-80. PubMed ID: 8228351 [TBL] [Abstract][Full Text] [Related]
13. Clinical trial of ampicillin v. trimethoprim-sulphamethoxazole in the treatment of Shigella dysentery. Yunus M; Mizanur Rahman AS; Farooque AS; Glass RI J Trop Med Hyg; 1982 Oct; 85(5):195-9. PubMed ID: 6757458 [TBL] [Abstract][Full Text] [Related]
14. Treatment of severe bacillary dysentery with trimethoprim alone. Bogaerts J; Habyalimana JB; Chevolet T; Vandepitte J Trans R Soc Trop Med Hyg; 1985; 79(2):203-5. PubMed ID: 3890282 [TBL] [Abstract][Full Text] [Related]
15. Convalescent cultures for control of shigellosis outbreaks. Turabelidze G; Bowen A; Lin M; Tucker A; Butler C; Fick F Pediatr Infect Dis J; 2010 Aug; 29(8):728-30. PubMed ID: 20661101 [TBL] [Abstract][Full Text] [Related]
16. Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella species in Guadalajara, Mexico. Bandres JC; Mathewson JJ; Ericsson CD; Dupont HL Am J Med Sci; 1992 May; 303(5):289-91. PubMed ID: 1580315 [TBL] [Abstract][Full Text] [Related]
17. [Clinico-bacteriological evaluation of the use of Cotrimexazole in the treatment of shigellosis in newborn infants]. Prado V; Banfi A; Donoso E; Ramírez B Rev Chil Pediatr; 1975; 46(1):25-9. PubMed ID: 1178946 [No Abstract] [Full Text] [Related]
18. Outbreaks of multidrug-resistant Shigella sonnei gastroenteritis associated with day care centers--Kansas, Kentucky, and Missouri, 2005. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(39):1068-71. PubMed ID: 17021592 [TBL] [Abstract][Full Text] [Related]
19. [Comparative randomized study on the clinico-bacteriological effectiveness of mecillinam versus cotrimexazole in shigellosis]. Prado V; Cohen J; Harun A; Aguirre X; Díaz C Rev Chil Pediatr; 1981; 52(2):118-24. PubMed ID: 6269160 [No Abstract] [Full Text] [Related]
20. Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections. Ellison RT; Judson FN; Peterson LC; Cohn DL; Ehret JM West J Med; 1984 May; 140(5):735-40. PubMed ID: 6610253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]